Delivery Order SPE2DB24D2010-SPE2DB24FZTF3
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $14,939.21 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,965,030 units of Otezla 30 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 30 mg Otezla tablets. The contract has a potential value of $3,397.17 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,367.37 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of Otezla 30mg tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Otezla 30 mg tablets. The contract has a potential value of $115,014.42 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is issued under a larger indefinite delivery...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $5,250.87 contract is for the delivery of Otezla 30 mg tablets over a period ending on April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) the company...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $25,968.74 and runs through August 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of OTEZLA 30 mg tablets. This contract, valued at $16,129.12, has an ultimate completion date of May 8, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $2,535.62 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of 60 tablets of the prescription medication Otezla 30 mg. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,656.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Otezla 30 mg tablets. The contract has a performance period through January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $43,491.98, is for the supply of 4,567,958,181 units of the medication Otezla 30 mg Tablet 60s. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZTF3Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,184,269 units of Otezla 30 mg tablets in packs of 60. This $36,865.62 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities worldwide. This IDC, which does not have any set-aside designations, serves as the primary contract vehicle for AmerisourceBergen to provide these critical healthcare materials to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.9k | 4/5/24 |